NTBL Notable Labs Ltd: Net Sales Margin

Notable Labs Ltd - graphic logo of issuer NTBL

Monthly sales margin dynamics demonstrate the risks of narrow specialization within the therapy forecasting IT system, while the value of 0.00 aligns with the current metric. Notable Labs, Ltd. (NTBL) generates revenue through precision oncology services for drug selection. The ecosystem integrates live-cell analysis with AI to determine treatment efficacy, creating a patient survival navigator.

Notable Labs Corp (NTBL) Net Margin: for the period 02/21/2024 - 11/02/2024

Notable Labs Corp (NTBL) - metric breakdowns and financial figures

- share price and expert price forecast:
Fundamental valuation:notablelabs.com - NTBL
Finished products of Notable Labs Inc.

Notable Labs, Ltd. (NTBL) is scaling its IT platform for predicting the efficacy of oncology drugs through the expansion of its B2B segment. The net profit margin trend reflects the portion of profit remaining after covering all operating and tax expenses. Comparing current values with the historical trend allows for the identification of structural shifts in business efficiency. This indicator measures the company's ability to convert revenue into net income, which is critical for assessing asset value during market capture.

Competitor analysis

ONC: Net Sales Margin|Net Margin Halozyme Inc. (HALO)|Net Margin RevMed|Net Return on Sales AAPG (Ascentage Pharma Group)|Net Sales Margin CGON|UroGen Pharma - Net Return on Sales|Bicara Therapeutics - Return on Sales by Net Profit|Net Sales Margin Personalis Inc PSNL|Erasca Oncology - Net Sales Margin|Net Profit Rate DCTH (Delcath Corp)|YMAB: Net Sales Margin|AURA - Company Sales Margin|CADL (Candel Therapeutics Inc.) - Net Sales Margin|Net Return on Sales ARAY (Accuray)|Return on Sales by Net Profit SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Net Margin|Net Margin Citius Oncology, Inc. CTOR|HURA - Return on Sales by Net Profit|protaratx.com - Net Sales Margin|FATE - Net Sales Margin|WHWK: Net Sales Margin|TScan Therapeutics (TCRX) - Net Sales Margin|Net Margin Champions Oncology|Net Margin XBIT|Net Sales Margin CVM|Return on Sales by Net Profit OS Therapies Inc. OSTX|Net Margin Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Net Margin|ANL - Net Margin|Net Margin verupharma.com|TPST: Net Sales Margin|XLO - Company Sales Margin|Net Margin Renovaro|Net Sales Margin muraloncology.com|Net Sales Margin KAPA|Company Sales Margin OnKure Therapeutics, Inc.|Net Sales Margin GDTC (w2.cytomed.sg)|CRIS - Return on Sales by Net Profit|Apollomics - Net Sales Margin|Tharimmune Corp (THAR) - Return on Sales by Net Profit|ADVB: Net Sales Margin|Return on Sales by Net Profit Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Net Sales Margin|Net Return on Sales SBFM (Sunshine Biopharma)|Net Margin Xenetic Bio (XBIO)|Net Margin SLRX (Salarius Pharma)|Kitov Pharma - Return on Sales by Net Profit|American Oncology Network (AONC) - Net Margin|BeiGene - Net Sales Margin|Checkpoint Therapeutics, Inc. (CKPT) - Return on Sales by Net Profit|ELEV (Elevation Oncology, Inc.) - Return on Sales by Net Profit|iCAD Inc. - Net Profit Rate|Return on Sales by Net Profit IKNA|VIRX: Net Profit Rate|Net Margin MorphoSys Corporation (MOR)|NAYA - Net Margin|Net Sales Margin AAPGV (Ascentage)